Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
TransThera a clinicalstage biopharmaceutical company dedicated to innovating differentiated drugs globally today announced the initiation of INDenabling studies for TT a potent selective and highly
Milestone Pharmaceuticals Inc today announced plans to resubmit the New Drug Application for etripamil to the US Food and Drug Administration for paroxysmal supraventricular tachycardia
Bitterroot Bio a leader in innovative treatments for cardiovascular diseases and Biotheus a pioneer in monoclonal and multispecific antibody design today announced a multiyear research collaboration
BioCity Biopharma is pleased to announce the completion of enrollment of all participants in the IgA nephropathy cohort in a randomized doubleblind placebocontrolled Phase clinical study of the novel
PK MED a biotechnology company developing injectable smart implants for drug release in rheumatology and cell homing for bone marrow transplantation today announced a significant potential breakthrough in
Oscotec Inc and ADEL Inc announced the dosing of the first healthy participant in its firstinhuman study of ADELY for the treatment of Alzheimers disease
The US Food and Drug Administration has accepted for Priority Review the supplemental Biologics License Application for Dupixent in a sixth potential indication as an addon maintenance treatment in certain adult
Leading independent health communications consultancy OVID Health have announced the opening of their innovative Patient Partnership Index the only international initiative which recognizes
Elevation Oncology Inc an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical
Gracell Biotechnologies Inc a global clinicalstage biopharmaceutical company developing innovative cell therapies for the treatment of cancer and autoimmune disease today announced the completion of its previously announced agreement to be acquired b...
